Neuralstem Rounding Second With Phase II ALS Trial
Seeking Alpha
Regenerative Medicine's Time Has Come
Seeking Alpha
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo
Investing In The Stem Cell Sector: An Overview
Seeking Alpha

